LAUSR

OBJECTIVE The genetic variations contributed to a substantial proportion of congenital vertebral malformations (CVMs). SOX9 gene, a member of the Sox gene family, have been implicated in CVM. To study the SOX9 mutation in CVM patients is of great significance to explain the pathogenesis of scoliosis (the clinical manifestation of CVM) and to explore the pathogenesis of SOX9-related skeletal deformities. METHODS A total of 50 singleton patients with CVM were included in this research. ES was performed on all the patients. The recurrent candidate variant of SOX9 gene was validated by Sanger sequencing. Luciferase assay was performed to investigate the functional changes of this variant. RESULTS A recurrent rare heterozygous missense variant in SOX9 gene (NM_000346.3: c.1405A>G, p.M469V) which had not been reported previously was identified in three CVM patients who had the clinical findings of congenital scoliosis without deformities in other systems. This variant was absent from public databases and our in-house database, it was predicted to be deleterious (CADD = 24.5). The luciferase assay demonstrated that transactivation capacity of the mutated SOX9 protein was significantly lower than that of the wild-type for the two luciferase reporters (p = 0.0202, p = 0.0082, respectively). CONCLUSION This SOX9 mutation (p.M469V) may contribute to CVM without other systematic deformity, which provided important implications and better understanding of phenotypic variability in SOX9-related skeletal deformities.